| 摘要 |
<p>It is intended to clarify a molecule which is available as a target in treating or diagnosing cancer and utilize the molecule in the medical field or the research field. By treating IgSF4, which has been identified as a molecule specifically expressed in lung cancer cells, with an antibody, an ADCC activity is exerted. Based on this finding, an anti-IgSF4 antibody is provided as a means efficacious in treating cancer, etc.</p> |
| 申请人 |
INSTITUTE FOR ANTIBODIES CO., LTD.;KUROSAWA, YOSHIKAZU;AKAHORI, YASUSHI;SUGIOKA, ATSUSHI;HAYASHI, NOBUHIRO;TAKASAKI, AKIHIKO;SUZUKI, KAZUHIRO;MORITA, MIWA;KUROSAWA, GENE;IBA, YOSHITAKA;SUMITOMO, MARIKO;TSUTSUMI, SUSUMU;OGAWA, KEIKO;MATSUDA, KAZUKI;MURAMATSU, CHIHO;TAKAHASHI, NOBUHIRO;FUJIYAMA, SARI;AZUMA, MASACHIKA;UKAI, YOSHINORI;MORISHITA, KAZUHIRO |
发明人 |
KUROSAWA, YOSHIKAZU;AKAHORI, YASUSHI;SUGIOKA, ATSUSHI;HAYASHI, NOBUHIRO;TAKASAKI, AKIHIKO;SUZUKI, KAZUHIRO;MORITA, MIWA;KUROSAWA, GENE;IBA, YOSHITAKA;SUMITOMO, MARIKO;TSUTSUMI, SUSUMU;OGAWA, KEIKO;MATSUDA, KAZUKI;MURAMATSU, CHIHO;TAKAHASHI, NOBUHIRO;FUJIYAMA, SARI;AZUMA, MASACHIKA;UKAI, YOSHINORI;MORISHITA, KAZUHIRO |
